The Trump administration is expected to release as soon as Thursday a highly anticipated report outlining Health Secretary ...

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal ...

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") announced today that warrant exchanges and exercises over the last four trading days have ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

‘Cook for Victory’, named to reference a war against ‘fake food’, is running online for another two weeks every evening live ...

Governor Brad Little and the Idaho Department of Health and Welfare submitted a formal request to the U.S. Department of ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

Hims research determined which fast food burgers have the healthiest nutritional content and which ones to save for a special ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...